Cancer Antigen-Breast (CA 15-3)

Casandra

Casandra Test Code AR16524Version 1 (DRAFT)

Performing Lab

Lab ARUP LaboratoriesLab Test ID 0080464CPT Code 86300

Cancer Antigen-Breast (CA 15-3)

Also known as: CA-BREAST

Clinical Use

Order Test

Use

The Cancer Antigen-Breast (CA 15-3) test is primarily used for monitoring therapy and identifying disease recurrence in individuals with metastatic breast cancer. It is not recommended for the diagnosis or screening of breast cancer. Patients undergoing treatment for Stage II and III breast cancer may benefit from this test, as it provides a quantitative measure of CA 15-3 levels that can indicate changes in disease status. Serial measurements are utilized in conjunction with other clinical assessments to monitor the progression of breast cancer. However, elevated CA 15-3 levels can also occur in nonmalignant conditions, hence the results should be interpreted cautiously and not used as stand-alone evidence for malignant disease.

Special Instructions

Not provided.

Limitations

The CA 15-3 test results are method-dependent, meaning results obtained through different methods or kits cannot be compared or used interchangeably. While the test is useful in monitoring known breast cancer cases, patients with confirmed carcinoma may have CA 15-3 values akin to those found in healthy individuals. Additionally, elevations in CA 15-3 levels may also be present in patients with certain nonmalignant diseases, which limits its specificity and diagnostic utility. Therefore, CA 15-3 levels alone should not be relied upon for determining the presence or absence of malignant breast cancer.

Test Details

FDA Approved

New York Approved

Methodology

Immunoassay (ECLIA)

Biomarkers

CA 15-3

Analyte

CA 15-3

Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)

LOINC Codes

Result Codes

6875-9 - Cancer Ag15-3 SerPl-aCnc

Result Turnaround Time

1 day

Specimen

Serum

Volume

1 mL

Minimum Volume

0.5 mL

Container

ARUP Standard Transport Tube

Collection Instructions

Allow specimen to clot completely at room temperature. Separate serum or plasma from cells as soon as possible or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube.